The Cognistat (neurobehavioural cognitive status exam): Administering the full test in stroke patients for optimal results

Rice, Danielle B; Campbell, Nerissa; Friedman, Lauren M.; Speechley, Mark; Teasell, Robert

doi:10.1111/1440-1630.12182

Cited by 3 publications

(5 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The researchers indicated that the Cognistat can be used a primary cognitive screen for the TBI population (Doninger et al, 2006). Rice, Campbell, Friedman, Speechley, and Teasell (2015) analyzed the psychometric properties of the Cognistat (2011) to determine if the screen-metric design was a reliable method to administer the Cognistat. Additionally, the researchers assessed the construct validity of the Cognistat within the CVA population.…”

Section: Cognitive Impairments In Abimentioning

confidence: 99%

“…The results showed inconsistency between five out of ten subscales. Some individuals who passed the screen items of the Cognistat failed the metric portion (Rice et al, 2015). The researchers suggested these findings indicated low sensitivity, and accuracy in detecting possible cognitive impairments using the screen-metric approach of the Cognistat in individuals with CVA (Rice et al, 2015).…”

Section: Cognitive Impairments In Abimentioning

confidence: 99%

“…Overall, reviewed literature has shown that the Cognistat is sensitive in detecting cognitive impairments in individuals with TBI or CVA, but lacks the ability to fully predict functional impairments (Doninger et al, 2006;Man, Tam, & Hui-Chan, 2006;Nøkleby et al, 2008). However, one piece of literature suggests the screen-metric method of administration is unreliable compared to administering the Cognistat with both screen and metric items (Rice et al, 2015). The Cognistat may be a valid tabletop cognitive assessment used in clinical practice for individuals with ABI.…”

Section: Cognitive Impairments In Abimentioning

confidence: 99%

“…The constraints of convenience sampling posed as a limitation for this study. The Additionally, a study conducted Rice et al, (2015) found that the Cognistat assessment screening tools did not identify impairment in individuals with ABI. Based on their findings, Rice et al, (2015) recommend that OT practitioners administer both the screen and the metric tool regardless of the screening tool result.…”

Section: Limitations and Recommendationmentioning

confidence: 99%

“…The Additionally, a study conducted Rice et al, (2015) found that the Cognistat assessment screening tools did not identify impairment in individuals with ABI. Based on their findings, Rice et al, (2015) recommend that OT practitioners administer both the screen and the metric tool regardless of the screening tool result. However, based on the standard assessment procedure as outlined in the Cognistat manual, the Cognistat was administered according to the best practices using the screening method.…”

Section: Limitations and Recommendationmentioning

confidence: 99%

See 4 more Smart Citations

Validation of the Medication Box Task Assessment

Blank¹,

Chandler²,

Isely³

et al.

View full text Add to dashboard Cite

There are a limited number of validated occupation-based cognitive assessments that are feasible in clinical settings. For individuals with acquired brain injury (ABI), ecologically valid cognitive assessments are needed to understand how cognition influences functional performance. This study implemented a quantitative exploratory correlational design using a battery of gold standard tabletop cognitive assessments as criterion measurements against the Medication Box Task assessment, an occupationbased cognitive assessment. Eight participants completed the test battery. The student researchers used Pearson correlations to analyze each participant's scores on the Medication Box Task assessment and the scores on the battery of gold standard assessments. Results indicated that no significant correlations existed between total scores of the battery of tabletop cognitive assessments and the Medication Box Task assessment. However significant correlations were found between scores of the total Type II errors made on the Tower of London and the total number of missing pills, extra pills, and total correct scores on the Medication Box Task assessment. Further findings indicated that seven out of eight participants made mistakes on the Medication Box Task assessment; six out of eight claimed that they managed their own medications.

show abstract

Section: Cognitive Impairments In Abimentioning

confidence: 99%

Section: Cognitive Impairments In Abimentioning

confidence: 99%

Section: Cognitive Impairments In Abimentioning

confidence: 99%

Section: Limitations and Recommendationmentioning

confidence: 99%

Section: Limitations and Recommendationmentioning

confidence: 99%

See 3 more Smart Citations

Validation of the Medication Box Task Assessment

Blank¹,

Chandler²,

Isely³

et al.

View full text Add to dashboard Cite

show abstract

Linking biomarkers with healthy lifestyle outcomes after stroke: Supplementary results of a 12-month randomized controlled trial

Swank,

McShan,

Bottiglieri

et al. 2024

Nutrition, Metabolism and Cardiovascular Diseases

View full text Add to dashboard Cite

Results of a 12-Month Randomized Controlled Trial Testing the Efficacy of the Diabetes Prevention Program Group Lifestyle Balance (DPP-GLB) for People Post Stroke (GLB-CVA)

Driver,

McShan,

Swank

et al. 2023

Annals of Behavioral Medicine

View full text Add to dashboard Cite

Background Experience of stroke is associated with an increased risk for diabetes and metabolic syndrome, yet few interventions exist that have been tailored to the population’s unique needs. Purpose To examine adherence and efficacy of the Diabetes Prevention Program Group Lifestyle Balance program (DPP-GLB) modified for individuals post stroke (GLB-CVA) using a randomized controlled trial. Methods Adults (18–85 years of age), >12 months post stroke, and body mass index ≥25 kg/m2 were included in this study. Sixty-five individuals were assigned to either the GLB-CVA intervention or a 6-month wait-list control. Participants completed the 12-month GLB-CVA intervention, with attendance and assessment of weight, anthropometric, biomarker, functional, and patient reported outcome data collected at baseline, 3, 6, and 12 months. Results High attendance (90%) and dietary and activity tracking (71%) suggest high adherence to the 12-month GLB-CVA. Six-month randomized controlled trial data indicate significant weight loss (p = .005) in the GLB-CVA group (7.4 ± 13.6 lbs, 3.65%) compared with the wait-list control (0.1 ± 10.1 lbs, 0%), and improvements in arm circumference (p = .04), high-density lipoprotein (HDL) cholesterol (p = .028), 8-year diabetes risk (p = .011), and pain interference (p < .001). Combined 12-month data showed participants lost 10.1 ± 16.8 lbs (4.88%) and improved waist circumference (p = .001), HbA1c (3.6%), diastolic blood pressure (p < .001), pain (p = .001), social participation (p = .025), and eating practices (p = .01) and habits (p < .001). Conclusions Engagement in the GLB-CVA can result in weight loss and improved health for individuals who are overweight or obese following stroke. Future efforts should examine effectiveness in real-world settings and focus on knowledge translation efforts.

show abstract

The Cognistat (neurobehavioural cognitive status exam): Administering the full test in stroke patients for optimal results

Cited by 3 publications

References 29 publications

Validation of the Medication Box Task Assessment

Validation of the Medication Box Task Assessment

Linking biomarkers with healthy lifestyle outcomes after stroke: Supplementary results of a 12-month randomized controlled trial

Results of a 12-Month Randomized Controlled Trial Testing the Efficacy of the Diabetes Prevention Program Group Lifestyle Balance (DPP-GLB) for People Post Stroke (GLB-CVA)

Contact Info

Product

Resources

About